(Total Views: 91)
Posted On: 01/26/2021 8:53:20 AM
Post# of 107025
EHVVF Golden Tickets!
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST
Press Release | 01/26/2021
MIAMI, Jan. 26, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) (the “Company”) announced today an upcoming complimentary Psychedelic Industry webinar for investors and interested individuals. The webinar is produced by PsyTech and titled “Progressive Applications of Ketamine - The Spearhead of Psychedelic Therapy.” Participants can expect a discussion on new approaches to ketamine-assisted treatment with the leading practitioners in the field. Participants will hear from the expert psychiatrists, anesthesiologists, and psychotherapists at the forefront of innovative – and highly impactful – therapeutic ketamine treatments.
The virtual investor webinar is open to individual investors, institutional investors, advisors, analysts and the Psychedelic Community. The program opens at 12:00 PM ET on Wednesday, January 27th. The webinar will be moderated by Mark Braunstein DO - Founder and CEO Reconscious Medical
Speakers for the PsyTech Virtual Investor Conference include:
Julane Andries, LMFT - Senior Psychotherapist Center for Transformational Psychotherapy
Phil Wolfson MD - CEO Non-Profit Ketamine Research Foundation
Steven L. Mandel MD - Founder & President Ketamine Clinics Los Angeles
Abid Nazeer MD Founder and President Aps Ketamine
Casey A. Paleos MD -Science Director Mindbloom
There are no fees to log-in, or attend the live presentations.
20/20 Global through Mycotopia Therapies owns 10% of PsyTech. Ehave, Inc. (EHVVF) controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave will continue develop Ketadash, the Ehave Dashboard, its MegaTeam video game applications for children with ADHD, the safety and security of Electronic Health Records (EHRs), improving mental health, and combatting mental illness.
About 20/20 Global and Mycotopia Therapy
Mycotopia Therapy focuses on helping you heal and reclaim your life. Your journey of healing is an understanding of the causes and works to mental wellness through psychedelic enhanced psychotherapy, integrated with a professional team of mental wellness practitioners and cutting-edge technology. Psychedelic therapy is a holistic and spiritual approach providing healing and has shown successful treatment for many years.
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST
Press Release | 01/26/2021
MIAMI, Jan. 26, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) (the “Company”) announced today an upcoming complimentary Psychedelic Industry webinar for investors and interested individuals. The webinar is produced by PsyTech and titled “Progressive Applications of Ketamine - The Spearhead of Psychedelic Therapy.” Participants can expect a discussion on new approaches to ketamine-assisted treatment with the leading practitioners in the field. Participants will hear from the expert psychiatrists, anesthesiologists, and psychotherapists at the forefront of innovative – and highly impactful – therapeutic ketamine treatments.
The virtual investor webinar is open to individual investors, institutional investors, advisors, analysts and the Psychedelic Community. The program opens at 12:00 PM ET on Wednesday, January 27th. The webinar will be moderated by Mark Braunstein DO - Founder and CEO Reconscious Medical
Speakers for the PsyTech Virtual Investor Conference include:
Julane Andries, LMFT - Senior Psychotherapist Center for Transformational Psychotherapy
Phil Wolfson MD - CEO Non-Profit Ketamine Research Foundation
Steven L. Mandel MD - Founder & President Ketamine Clinics Los Angeles
Abid Nazeer MD Founder and President Aps Ketamine
Casey A. Paleos MD -Science Director Mindbloom
There are no fees to log-in, or attend the live presentations.
20/20 Global through Mycotopia Therapies owns 10% of PsyTech. Ehave, Inc. (EHVVF) controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave will continue develop Ketadash, the Ehave Dashboard, its MegaTeam video game applications for children with ADHD, the safety and security of Electronic Health Records (EHRs), improving mental health, and combatting mental illness.
About 20/20 Global and Mycotopia Therapy
Mycotopia Therapy focuses on helping you heal and reclaim your life. Your journey of healing is an understanding of the causes and works to mental wellness through psychedelic enhanced psychotherapy, integrated with a professional team of mental wellness practitioners and cutting-edge technology. Psychedelic therapy is a holistic and spiritual approach providing healing and has shown successful treatment for many years.
(0)
(0)
